#$%^&*AU2013263799B220160211.pdf#####ABSTRACT A method of treating newly diagnosed multiple myeloma, which comprises administering to a patient having newly diagnosed multiple myeloma: (a) about 1 to about 50 5 mg per day of a compound 3-(4-amino-l-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione, or a pharmaceutically acceptable salt, solvate or stereoisomer thereof and (b) a therapeutically effective amount of dexamethasone. C: poi word SPEC-986217[1].docx